Anzeige
Mehr »
Sonntag, 01.03.2026 - Börsentäglich über 12.000 News
Erste Psilocybin-Behandlungen laufen - warum steht Optimi noch bei Pennystock-Level?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14THD | ISIN: US2290503075 | Ticker-Symbol: CKX
Frankfurt
27.02.26 | 08:10
7,000 Euro
+0,72 % +0,050
Branche
Logistik/Transport
Aktienmarkt
Sonstige
1-Jahres-Chart
CRYOPORT INC Chart 1 Jahr
5-Tage-Chart
CRYOPORT INC 5-Tage-Chart
RealtimeGeldBriefZeit
7,0507,10019:05
7,0507,25027.02.

Aktuelle News zur CRYOPORT Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
11.02.EXCLUSIVE: New Fusion 800 Launch Signals Cryoport's Ambition To Modernize Cryogenic Storage1
06.11.25Cryoport, Inc. - 10-Q, Quarterly Report-
CRYOPORT Aktie jetzt für 0€ handeln
05.11.25Needham raises CryoPort stock price target to $12 on strong Q3 results1
05.11.25Cryoport updates 2025 revenue outlook to $170M-$174M while expanding global supply chain infrastructure1
05.11.25Cryoport Q3 2025 presentation: 15% revenue growth with improving margins3
04.11.25Cryoport Inc: EPS übertrifft Schätzungen um 0,06 $ - Umsatz besser als erwartet-
04.11.25CryoPort GAAP EPS of -$0.18 beats by $0.03, revenue of $44.2M beats by $2.98M1
04.11.25Cryoport Reports Strong Q3 Results, Raises FY25 Outlook3
04.11.25Cryoport, Inc. - 8-K, Current Report-
04.11.25Cryoport, Inc.: Cryoport Reports Third Quarter 2025 Financial Results137Third quarter revenue increased 15% year-over-year to $44.2 million Commercial Cell & Gene Therapy revenue increased 36% year-over-year to $8.3 million ...
► Artikel lesen
30.10.25Cryoport Systems Secures ISO Certification for Cell Therapy Transport Standards2
30.10.25Cryoport becomes first supply chain firm to achieve ISO 21973 certification1
01.10.25Cryoport Adds New Global Supply Chain Center in Louvres, France1
18.09.25Analyst Expectations For CryoPort's Future2
05.08.25Cryoport, Inc.: Cryoport Reports Second Quarter 2025 Financial Results201Second quarter revenue increased 14% year-over-year to $45.5 million Commercial Cell & Gene Therapy revenue increased 33% year-over-year to $8.7 million Life...
► Artikel lesen
12.06.25Cryoport, Inc.: Cryoport Completes CRYOPDP Divestiture and Commences Strategic Partnership with DHL Group1.035NASHVILLE, Tenn., June 12, 2025 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a leader in temperature-controlled supply chain...
► Artikel lesen
07.05.25Cryoport, Inc.: Cryoport Reports First Quarter 2025 Financial Results587Commercial Cell & Gene therapy revenue of $7.2 million, up 33% year over year Q1 2025 revenue from continuing operations of $41.0 million, up 10% year over year ...
► Artikel lesen
31.03.25Cryoport, Inc.: DHL Group acquires CRYOPDP from Cryoport to strengthen "DHL Health Logistics"460DHL to acquire 100% of CRYOPDP, a leading specialty courier providing logistics services for clinical trials, biopharma, and cell & gene therapies. This acquisition...
► Artikel lesen
04.03.25Cryoport, Inc.: Cryoport Reports Fourth Quarter and Full Year 2024 Financial Results636FY 2024 revenue of $228.4 million, in-line with company guidance Commercial Cell & Gene Therapy revenue rose to $26 million in FY 2024, up 20% year-over-year...
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1